XTMAB-16-201: A seamless, Phase 1b/2 multiple ascending dose/proof of concept study of XTMAB-16 inpatients with pulmonary sarcoidosis with or without extrapulmonary manifestations

Project: Research project

Project Details

Description

XTMAB-16-201: A seamless, Phase 1b/2 multiple ascending dose/proof of concept study of XTMAB-16 in patients with pulmonary sarcoidosis with or without extrapulmonary manifestations
StatusActive
Effective start/end date1/1/2412/31/26

Funding

  • XENTRIA, INC

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.